Covered recipient · General Payments record
ELIZABETH J GOODWIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$687.82
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $208.53 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $81.31 | 4 |
| Acerta Pharma LLC | $38.51 | 2 |
| Astellas Pharma US Inc | $30.80 | 2 |
| GlaxoSmithKline, LLC. | $22.43 | 1 |
| Merck Sharp & Dohme Corporation | $18.16 | 1 |
| Lilly USA, LLC | $17.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $13.82 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139477482 | CMS |
| Astellas Pharma US Inc | $16.98 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139554157 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.93 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104651877 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.58 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105604591 | CMS |
| GlaxoSmithKline, LLC. | $22.43 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116261577 | CMS |
| Lilly USA, LLC | $17.32 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135635766 | CMS |
| Merck Sharp & Dohme LLC | $18.16 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141931669 | CMS |
| Novo Nordisk Inc | $20.58 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100294842 | CMS |
| Novo Nordisk Inc | $18.06 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100225734 | CMS |
| Novo Nordisk Inc | $17.67 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100604228 | CMS |
| Novo Nordisk Inc | $25.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100639010 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.